EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access · CC BY 4.0

Antenatal corticosteroids and perinatal outcome in late fetal growth restriction: analysis of prospective cohort

A Familiari iD, R Napolitano iD, G H A Visser iD, C Lees iD, H Wolf iD, F Prefumo iD, TRUFFLE-2 feasibility study investigators

Ultrasound in Obstetrics & Gynecology · 2023

DOI: 10.1002/uog.26127 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Ultrasound in Obstetrics & Gynecology, 2023. Verfasst von A Familiari und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Fetal Growth Retardation, Infant, Small for Gestational Age. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the role of antenatal administration of corticosteroids for fetal lung maturation on the short‐term perinatal outcome of pregnancy complicated by late fetal growth restriction (FGR).

Methods

This cohort study was a secondary analysis of a multicenter prospective observational study, the TRUFFLE‐2 feasibility study, conducted between 2017 and 2018 in 33 European perinatal centers. The study included women with a singleton pregnancy from 32 + 0 to 36 + 6 weeks of gestation with a fetus considered at risk for FGR, defined as estimated fetal weight (EFW) and/or fetal abdominal circumference < 10 th percentile, or umbilicocerebral ratio (UCR) ≥ 95 th percentile or a drop of more than 40 percentile points in abdominal circumference measurement from the 20‐week scan. For the purposes of the current study, we identified women who received a single course of steroids to improve fetal lung maturation before delivery. Each exposed pregnancy was matched with one that did not receive antenatal corticosteroids (ACS) (control), based on gestational age at delivery and birth weight. The primary adverse outcome was a composite of abnormal condition at birth, major neonatal morbidity or perinatal death.

Results

A total of 86 pregnancies that received ACS were matched to 86 controls. The two groups were similar with respect to gestational age (33.1 vs 33.3 weeks), EFW (1673 vs 1634 g) and UCR (0.68 vs 0.62) at inclusion, and gestational age at delivery (35.5 vs 35.9 weeks) and birth weight (1925 vs 1948 g). No significant differences were observed between the exposed and non‐exposed groups in the incidence of composite adverse outcome (28% vs 24%; P = 0.73) or any of its elements.

Conclusion

The present data do not show a beneficial effect of steroids on short‐term outcome of fetuses with late FGR. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fetal Growth RetardationInfant, Small for Gestational AgeInfant, NewbornPregnancyFemaleHumansInfantBirth WeightCohort StudiesProspective StudiesUltrasonography, PrenatalParturitionFetal WeightGestational AgeAdrenal Cortex Hormones

Stichwörter der Autor:innen

antenatal corticosteroidsfetal growth restrictionfetal lung maturationlate preterm

Substanzen

Adrenal Cortex Hormones

Autor:innen und Institutionen

  • Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, UK.
  • Fetal Medicine Unit, University College London Hospitals NHS Foundation Trust, London, UK.
  • Department of Obstetrics, University Medical Center, Utrecht, The Netherlands.
  • Centre for Fetal Care, Department of Obstetrics and Gynaecology, Queen Charlotte's and Chelsea Hospital, Imperial College London, London, UK.
  • Department of Obstetrics and Gynecology, Amsterdam University Medical Center (Location AMC), University of Amsterdam, Amsterdam, The Netherlands.

ORCID-Profile: A Familiari, R Napolitano, G H A Visser, C Lees, H Wolf, F Prefumo

Zitieren

APA

Familiari, A., Napolitano, R., Visser, G. H. A., Lees, C., Wolf, H., Prefumo, F., & TRUFFLE-2 feasibility study investigators (2023). Antenatal corticosteroids and perinatal outcome in late fetal growth restriction: analysis of prospective cohort. Ultrasound in Obstetrics & Gynecology. https://doi.org/10.1002/uog.26127

Vancouver

Familiari A, Napolitano R, Visser GHA, Lees C, Wolf H, Prefumo F, et al. Antenatal corticosteroids and perinatal outcome in late fetal growth restriction: analysis of prospective cohort. Ultrasound in Obstetrics & Gynecology. 2023. doi:10.1002/uog.26127

BibTeX
@article{Familiari2023,
  author = {Familiari, A and Napolitano, R and Visser, G H A and Lees, C and Wolf, H and Prefumo, F and TRUFFLE-2 feasibility study investigators, TRUFFLE-2 feasibility study investigators},
  title = {Antenatal corticosteroids and perinatal outcome in late fetal growth restriction: analysis of prospective cohort},
  journal = {Ultrasound in Obstetrics & Gynecology},
  year = {2023},
  doi = {10.1002/uog.26127}
}
Kostenlos starten →